# Biodesix Inc: Form 8-K, filed Feb 14, 2022

- Company: [Biodesix Inc](/companies/bdsx.md) (CIK 1439725)
- Form: 8-K
- Filed: 2022-02-14
- Accepted by EDGAR: Feb 14, 2022, 08:01 ET
- Period: 2022-02-14
- Accession: 0000950170-22-001157
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1439725/000095017022001157/bdsx-20220214.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1439725/000095017022001157/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1439725/000095017022001157/bdsx-20220214.htm

Filed Feb 14, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-001157. Last ingested by Listed: Nov 12, 2026, 19:59 ET. No prices; not investment advice.